Aragon Pharmaceuticals

About:

Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.

Website: http://www.aragonpharmaceuticals.com

Top Investors: OrbiMed, The Column Group, venBio Partners, Aisling Capital, Topspin Partners

Description:

Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.

Total Funding Amount:

$122M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)aragonpharmaceuticals.com

Founders:

Richard Heyman

Number of Employees:

11-50

Last Funding Date:

2012-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai